Viewing data from:

IVERMECTIN

ANDA

IVERMECTIN | A215922 | RUBICON RESEARCH LTD

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: STROMECTOL(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$9.68

per ea

Lowest NADAC/Unit

$2.17

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
72888020766IVERMECTIN 6 MG TABLET	$9.68	EA	Generic	—	2026-06-17
72888020666IVERMECTIN 3 MG TABLET	$2.17	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain4 active DMFs3 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

HOVIONE PHARMASCIENCE LTDIVERMECTIN USP

DMF 213952008

ZHEJIANG HISUN PHARMACEUTICAL CO LTDIVERMECTIN USP

DMF 216242008

INDUSTRIALE CHIMICA SRLIVERMECTIN PH. FUR.

DMF 364942021

HEBEI MEIHE PHARMACEUTICAL CO LTDIVERMECTIN

DMF 385532023

HAIMEN PHARMACEUTICAL FACTORYInactiveIVERMECTIN, NON-STERILE BULK DRUG

DMF 127551997

SHANGHAI TONGREN PHARMACEUTICAL CO LTDInactiveIVERMECTIN

DMF 130371998

DELTA TECH LTDInactiveIVERMECTIN

DMF 176732004

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Feb 19, 2025	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — 3MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jan 22, 2025

No patent or exclusivity listings for this strength.

#002 — 6MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jan 22, 2025